Relay Therapeutics (RLAY) FCF Margin (2021 - 2026)
Relay Therapeutics (RLAY) posted FCF Margin of -15459.71% for Q2 2026, down 7293.24 percentage points from -8166.47% a year earlier and down 13755.98 percentage points from the prior quarter.
Powered by 
Analysis
Relay Therapeutics (RLAY) FCF Margin (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at Relay Therapeutics was -2050.29%, up 1085.89 percentage points year-over-year; for FY2025, it was -1536.08%, up 973.41 percentage points from FY2024.
- Annual FCF Margin shows a five-year change of -1409.75 percentage points (FY2020 to FY2025).
- In prior years, Relay Therapeutics' FCF Margin was -2509.49% in FY2024 (-1317.75 pp), -1191.74% in FY2023 (+16082.12 pp), -17273.86% in FY2022 (-14702.81 pp) and -2571.05% in FY2021 (-2444.71 pp).
- The Q2 2026 figure stands as the lowest quarterly FCF Margin since Q2 2023.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q1 2024, with a gain of 30030.22 percentage points; the weakest was Q2 2023, with a drop of 42760.24 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Relay Therapeutics | 3.87 Bn | 3.87 Bn | - | -15,459.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,459.71% |
| Mar 31, 2026 | -1,703.73% |
| Dec 31, 2025 | -640.94% |
| Jun 30, 2025 | -8,166.47% |
| Mar 31, 2025 | -958.38% |
| Mar 31, 2024 | -520.67% |
| Sep 30, 2023 | -301.51% |
| Jun 30, 2023 | -58,910.92% |
| Mar 31, 2023 | -30,550.88% |
| Dec 31, 2022 | -23,476.28% |
| Sep 30, 2022 | -19,837.21% |
| Jun 30, 2022 | -16,150.68% |
| Mar 31, 2022 | -12,402.63% |
| Dec 31, 2021 | -7,158.20% |
| Sep 30, 2021 | -8,248.50% |
| Jun 30, 2021 | -3,379.03% |
| Mar 31, 2021 | 4,849.16% |
API Access
Relay Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=RLAY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "RLAY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=RLAY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();